Browsing: Commentary
Guest commentary articles from industry experts from across the longevity and mortality markets. If you would like to submit an article for consideration for publishing by Longevity and Mortality Investor, please click here.
All in all, as counterparties for longevity and mortality risk investors, US life insurers remain strong.
The broader consequences of climate change are complex and far-reaching, with significant implications for human health, financial systems and the wider economy.
As with previous years, the US life insurance industry had a solid 2024 from a balance sheet perspective and continues to be healthy from a risk perspective.
The past four decades have brought revolutionary improvements in cancer care, transforming many forms of cancer from fatal diagnoses into chronic, manageable conditions.
Within the life settlement industry, the medical record review has long remained one of the most resource-intensive and time-consuming stages of the process but recent advancements in automation and artificial intelligence, however, are beginning to change this dynamic.
Litigation risk in the life settlement market takes multiple forms, from cost of insurance increases to estate challenges, from credit risk to stranger-owned life insurance cases. Liam Bodemeaid, Actuarial Consultant at Actuarial Risk Management, introduces a new framework to price litigation risk with a little bit more logic, data, and structure in a guest article.
The success story of rising life expectancy is far from over, but it is evolving. For pensions and insurance, the challenge is to reflect short-term headwinds without losing sight of long-term potential.
The life settlement market has never been more mature and experienced, and ELSA is well placed to continue to lead from the front in terms of the awareness and education effort, driving standards, and fostering collaboration among market participants to push the industry to higher highs.
The life settlement market isn’t just a niche for policy sales; it’s a goldmine of mortality data that can elevate financial advising. By looking beyond traditional sources and embracing these insights, financial advisors could produce more accurate retirement income models for their clients and their businesses.
GMP Equalisation is continuing to be a significant hurdle for DB pension schemes on the final stretch to buyout but with the right tools, support and technology, these obstacles don’t have to derail transactions.